Non-ST Elevation Myocardial Infarction in the Elderly. Antithrombotic Therapy and Beyond
Pablo Díez-Villanueva1, César Jiménez-Méndez2, José Luis Ferreiro3,4
1Cardiology Department, Hospital Universitario La Princesa, 28006 Madrid, Spain.
Insights
Elderly patients with non-ST elevation myocardial infarction (NSTEMI) require careful antithrombotic therapy due to risks of clotting and bleeding. This review covers drug considerations and geriatric factors impacting NSTEMI management in older adults.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Non-ST segment elevation myocardial infarction (NSTEMI) is the most common acute coronary syndrome in the elderly.
- Antithrombotic therapy is crucial for acute ischemic events but requires balancing thrombotic and bleeding risks, especially in older individuals.
Purpose of the Study:
- To review antithrombotic therapy in elderly patients with NSTEMI.
- To discuss pharmacokinetic and pharmacodynamic aspects, clinical situations, and the impact of geriatric conditions on NSTEMI management.
Main Methods:
- Literature review focusing on antithrombotic therapy in elderly NSTEMI patients.
- Analysis of pharmacokinetic and pharmacodynamic data.
- Consideration of geriatric factors like frailty.
Main Results:
- Elderly patients present unique challenges in antithrombotic therapy due to altered drug metabolism and increased bleeding risk.
- Frailty and other geriatric conditions are associated with poorer prognoses in elderly cardiovascular disease patients.
Conclusions:
- Antithrombotic treatment in elderly NSTEMI patients necessitates individualized approaches considering drug properties and patient-specific geriatric factors.
- Further research is needed to optimize antithrombotic strategies for this vulnerable population.
Abstract:
Non-ST segment elevation myocardial infarction (NSTEMI) is the most frequent type of acute coronary syndrome in the elderly. Antithrombotic therapy is the cornerstone of pharmacological therapy in the setting of an acute ischemic event, a clinical scenario in which thrombotic and bleeding risks ought to be considered, particularly in older patients. In this article, specific aspects of antithrombotic therapy in elderly patients with NSTEMI are reviewed, including pharmacokinetic and pharmacodynamic characteristics and different clinical situations. The role of frailty and other common geriatric conditions, that are associated with worse prognosis in elderly patients with cardiovascular disease, is also addressed.
More Related Videos
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:16Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....